FDA Adverse Event Injury Summary report: N

CONTEGRA PULMONARY VALVED CONDUIT

MDR report key: 1070929 · Received July 8, 2008

Report

Report Number
2025587-2008-00054
Event Type
Injury
Date Received
July 8, 2008
Date of Event
May 9, 2008
Report Date
July 2, 2008
Manufacturer
MEDTRONIC HEART VALVES, INC.
Product Code
MWH
PMA / PMN Number
H020003
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ANALYSIS: UPON RECEIPT, A 2.2CM SECTION OF THE VALVE CONDUIT WAS CONTAINED IN A CLEAR, 0.2% GLUTARALDEHYDE SOLUTION. VISUAL INSPECTION OF THE LEAFLETS REVEALED THEY WERE FLEXIBLE. FURTHER INSPECTION NOTED GLISTENING OFF-WHITE PANNUS THAT THINLY LINED THE INNER WALL OF THE CONDUIT. A THICKER SECTION WAS NOTED THROUGH THE INFLOW AND OUTFLOW ORIFICES. AN UNK AMOUNT OF PANNUS AROUND THE INFLOW AND OUTFLOW ORIFICES MAY HAVE BEEN REMOVED DURING EXPLANT. A RADIOGRAPH REVEALED MODERATE MINERALIZATION IN THE HOST TISSUE AND CONDUIT WALL ADJACENT TO THE INFLOW ORIFICE. CONCLUSION: REDUCED PERFORMANCE OF THE DEVICE DUE TO HOST TISSUE OVERGROWTH AND MINERALIZATION, CONDITIONS GENERALLY ATTRIBUTED TO THE PT. THE PRODUCT WAS EXPLANTED AND REPLACED WITH NO REPORTED ADVERSE PT OUTCOMES.

Description of Event or Problem · 1

MEDTRONIC RECEIVED INFO THAT APPROX THREE YRS POST IMPLANT, ECHOCARDIOGRAPHIC AND CATHETER IMAGING OF THIS BIOPROSTHETIC PULMONARY VALVE REVEALED CENTRAL REGURGITATION AND DILATATION, DUE TO PULMONARY ARTERY STENOSIS (UNIFOCALIZED MARCAS). THE VALVE WAS REMOVED, REPLACED, AND RETURNED FOR ANALYSIS. THE PHYSICIAN DID NOT EXPRESS DISSATISFACTION WITH THE PERFORMANCE OF THE VALVE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 CONTEGRA PULMONARY VALVED CONDUIT MWH MEDTRONIC HEART VALVES, INC. 200 NA

Patients

Seq Age Sex Outcome Treatment
1 3 YR Hospitalization| R